Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
ConditionGiant Cell Arteritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorUniversity of Pennsylvania
About this trial
The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).
Eligibility criteria
Qualifiers
Age 50 years or older
First presentation of suspected GCA
New or worsening cranial manifestations within 4 weeks of enrollment concerning for active GCA
Elevated CRP greater than 1.0 mg/dl
Disqualifiers
Absence of cranial symptoms related to GCA (e.g., only large vessel GCA)
Trial design
Treatments tested in this trial
- Magnetic Resonance Imaging (MRI)
Treatment groups
400 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Pennsylvania
Lead sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Source ClinicalTrials.gov